Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577096 · ClinicalTrials.gov registry record · NA
Effects of Exercise in Combination With Epoetin Alfa
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT00577096 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 120 participants.
The verdict
NCT00577096, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of the study was to determine the effect of Epoetin alfa therapy (short term versus long term) with and without a home-based individualized exercise program that incorporated aerobic and strength resistance training for patients being treated with high-dose chemotherapy and autologous peripheral bloodstem cell transplantation (PBSC T) for multiple myeloma. The endpoints for the study included the number of attempts at and total number of days of stem cell collection, number of RBC and platelet transfusions during the transplantation period, time-to-recovery after transplantation, and response to intensive therapy for multiple myeloma.
Interventions
- BEHAVIORAL Exercise
- DRUG Epoetin Alfa
- DRUG Thalidomide
- BIOLOGICAL Red Blood Cell Transfusion
- BIOLOGICAL Autologous Peripheral Blood Stem Cell Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2001-10 |
| Est. Completion | 2004-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00577096
The ClinicalTrials.gov registry entry for NCT00577096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Exercise is the first listed.
NCT00577096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00577096 about?
NCT00577096 is a clinical study titled "Effects of Exercise in Combination With Epoetin Alfa". The purpose of the study was to determine the effect of Epoetin alfa therapy (short term versus long term) with and without a home-based individualized exercise program that incorporated aerobic and strength resistance training for patients being treated with high-dose chemotherapy and autologous pe...
What is the current status of trial NCT00577096?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2001-10. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00577096?
The interventions under investigation include: Exercise (BEHAVIORAL), Epoetin Alfa (DRUG), Thalidomide (DRUG), Red Blood Cell Transfusion (BIOLOGICAL), Autologous Peripheral Blood Stem Cell Transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT00577096?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.